BioRem Inc.
BRM.V · TSXV
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CA$48,082 | CA$15,672 | CA$13,627 | CA$32,330 |
| - Cash | CA$5,213 | CA$2,292 | CA$3,775 | CA$4,471 |
| + Debt | CA$3,557 | CA$4,185 | CA$4,746 | CA$5,666 |
| Enterprise Value | CA$46,426 | CA$17,566 | CA$14,598 | CA$33,524 |
| Revenue | CA$37,419 | CA$25,165 | CA$28,863 | CA$24,478 |
| % Growth | 48.7% | -12.8% | 17.9% | – |
| Gross Profit | CA$10,056 | CA$7,022 | CA$8,762 | CA$6,236 |
| % Margin | 26.9% | 27.9% | 30.4% | 25.5% |
| EBITDA | CA$4,817 | CA$3,445 | CA$2,991 | CA$2,677 |
| % Margin | 12.9% | 13.7% | 10.4% | 10.9% |
| Net Income | CA$3,044 | CA$2,179 | CA$1,613 | CA$1,297 |
| % Margin | 8.1% | 8.7% | 5.6% | 5.3% |
| EPS Diluted | 0.16 | 0.13 | 0.092 | 0.035 |
| % Growth | 23.1% | 41.5% | 164.8% | – |
| Operating Cash Flow | CA$3,685 | CA$490 | CA$1,445 | CA$3,782 |
| Capital Expenditures | -CA$372 | -CA$553 | -CA$203 | -CA$76 |
| Free Cash Flow | CA$3,313 | -CA$63 | CA$1,242 | CA$3,706 |